Literature DB >> 23133

Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.

H H Harms, L Gooren, A J Spoelstra, C Hesse, L Verschoor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 23133      PMCID： PMC1429223          DOI： 10.1111/j.1365-2125.1978.tb01593.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  20 in total

1.  Influence of metoprolol and propranolol on hemodynamic effects induced by physical work and isoprenaline.

Authors:  G Johnsson; G Nyberg; L Sölvell
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

Review 2.  A survey of the pharmacological properties of metoprolol in animals and man.

Authors:  B Ablad; K O Borg; E Carlsson; L EK; G Johnson; T Malmfors; C G Regårdh
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

3.  Stereochemical aspects of beta-adrenoceptor antagonist-receptor interaction in adipocytes. Differentiation of beta-adrenoceptors in human and rat adipocytes.

Authors:  H H Harms
Journal:  Life Sci       Date:  1976-11-01       Impact factor: 5.037

4.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

5.  Metabolic responses to selective beta-adrenergic stimulation in man.

Authors:  R Goldberg; M van As; B I Joffe; L Krut; I Bersohn; H C Seftel
Journal:  Postgrad Med J       Date:  1975-02       Impact factor: 2.401

6.  Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.

Authors:  F R Bühler; F Burkart; B E Lütold; M Küng; G Marbet; M Pfisterer
Journal:  Am J Cardiol       Date:  1975-10-31       Impact factor: 2.778

7.  Beta-adrenoceptor studies. III. On the beta-adrenoceptors in rat adipose tissue.

Authors:  H H Harms; J Zaagsma; B Van der Wal
Journal:  Eur J Pharmacol       Date:  1974-01       Impact factor: 4.432

8.  Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.

Authors:  H Aström; H Vallin
Journal:  Br Heart J       Date:  1974-12

9.  Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors.

Authors:  H H Harms
Journal:  J Pharmacol Exp Ther       Date:  1976-11       Impact factor: 4.030

10.  Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.

Authors:  B Basil; R Jordan; A H Loveless; D R Maxwell
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739
View more
  26 in total

Review 1.  The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

2.  The influence of beta-adrenoceptor blocking drugs with and without intrinsic sympathomimetic activity on the hormonal responses to hypo- and hyperglycaemia.

Authors:  K J Schlüter; W H Aellig; K G Petersen; H C Rieband; A Wehrli; L Kerp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Effects of prazosin and alphamethyldopa on blood lipids and lipoproteins in hypertensive patients.

Authors:  M Velasco; H Silva; E Feldstein; R Pellicer; J Morillo; A Urbina-Quintana; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

5.  Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.

Authors:  L D Lameijer; L A Voermans; J J Houtzagers; D R Chadha
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.

Authors:  J M Arnold; P C O'Connor; J G Riddell; D W Harron; R G Shanks; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

Review 7.  Interactions of NSAIDs with diuretics and beta-blockers mechanisms and clinical implications.

Authors:  J Webster
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

8.  A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia.

Authors:  J Saunders; R Gomeni; J R Kilborn; P L Morselli; P H Sönksen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Antidepressant drugs, convulsions and epilepsy.

Authors:  A Richens; S Nawishy; M Trimble
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

Review 10.  Effects of antihypertensive drugs on endocrine function.

Authors:  E P Brass
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.